Cargando…
Medications in Patients with Dementia and Behavioral Disturbance
BACKGROUND: Behavioral disturbance (BD) is common in dementia patients, with no FDA approved medications for this condition. Little data exists on the real-world medication use in this population. OBJECTIVE: To describe real-world medications use in this population. METHODS: A cross-sectional study...
Autores principales: | Zhong, Wenjun, Liu, Xinyue, Voss, Tiffini, Khalilieh, Sauzanne, Khandker, Rezaul Karim, Bortnichak, Edward, Liaw, Kai-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293669/ https://www.ncbi.nlm.nih.gov/pubmed/34368636 http://dx.doi.org/10.3233/ADR-210023 |
Ejemplares similares
-
Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD)
por: DiBello, Julia R., et al.
Publicado: (2023) -
Diagnosis of behavioral symptoms as a predictor of institutionalization among Medicaid patients with dementia
por: Khandker, Rezaul Karim, et al.
Publicado: (2023) -
Economic outcomes associated with diagnosed behavioral symptoms among patients with dementia in the United States: a health care claims database analysis
por: Khandker, Rezaul Karim, et al.
Publicado: (2023) -
Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug–Drug Interactions
por: Khalilieh, Sauzanne, et al.
Publicado: (2020) -
Behavioral disturbances in dementia
por: Müller-Spahn, Franz
Publicado: (2003)